Holen Sie sich die Stockscreener-App
5.05
6.54%
0.31
Schlusskurs vom Vortag:
$4.74
Offen:
$4.7
24-Stunden-Volumen:
15,406
Relative Volume:
1.97
Marktkapitalisierung:
$7.92M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-7.24M
KGV:
-19.77
EPS:
-0.2554
Netto-Cashflow:
$-11.29M
1W Leistung:
+10.75%
1M Leistung:
+20.30%
6M Leistung:
-39.90%
1J Leistung:
-96.44%
1-Tages-Spanne:
$4.64
$5.40
1-Wochen-Bereich:
$4.22
$5.40
52-Wochen-Spanne:
$3.576
$183.59
Curanex Pharmaceuticals Inc Stock (CURX) Company Profile
Firmenname
Curanex Pharmaceuticals Inc
Sektor
Branche
Telefon
718-673-6078
Adresse
2 JERICHO PLAZA,, JERICHO
Compare CURX vs VRTX, REGN, ARGX, MRNA, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CURX
Curanex Pharmaceuticals Inc
|
5.05 | 8.26M | 0 | -7.24M | -11.29M | -0.2554 |
VRTX
Vertex Pharmaceuticals Inc
|
546.12 | 136.93B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
827.72 | 85.11B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
1,033.15 | 64.95B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
145.55 | 53.23B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
210.02 | 45.38B | 742.00K | -1.37B | -1.07B | -7.0731 |
Curanex Pharmaceuticals Inc Aktie (CURX) Neueste Nachrichten
Curanex Announces Reverse Stock Split to Maintain Nasdaq Listing - TipRanks
Curanex Pharmaceuticals Inc Common Stock (NASDAQ: CURX) Stock Price, News & Analysis - Kalkine
Enterprise value to EBIT forward of Curanex Pharmaceuticals Inc – NASDAQ:CURX - TradingView
Curanex Pharmaceuticals Inc Q2 2026: Net income $(3.29M), EPS $(0.12) — 10-Q Summary - TradingView
CURX: Net loss rose to $6.4M as R&D spending increased; cash shortfall raises going concern doubts - TradingView
Curanex Pharmaceuticals (CURX) Edges Up 3.68% as Micro-Cap Biotech Holds Key SupportVWAP Breakout - Vinanet
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Curanex Pharmaceuticals (CURX) Jumps 7.33% to $0.20 as Buyers Defend Key Support ZonePrice Target - dars.gov.et
Curanex Pharmaceuticals (CURX) Advances 7.33% as Shares Approach Key Resistance at $0.21Dark Pool Prints - dars.gov.et
Curanex Pharmaceuticals Inc - TradingKey
Curanex Pharmaceuticals (CURX) Holds at $0.20 as Modest Gain Breaks Recent StagnationExtension Target - vinanet.vn
Curanex Pharmaceuticals (CURX) Gains 8.2% as Stock Approaches Key ResistanceMFI Divergence - vinanet.vn
CURX|Curanex Pharmaceuticals Inc|Price:0.183|Chg%:-0.005 - TradingKey
Curanex Pharmaceuticals Inc (CURX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Curanex Pharmaceuticals Inc (CURX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
CURX|Curanex Pharmaceuticals Inc|Price:0.205|Chg%:+0.014 - TradingKey
Curanex Pharmaceuticals Inc (CURX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Curanex Pharmaceuticals Inc (CURX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Curanex Pharmaceuticals Inc (CURX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Curanex Pharmaceuticals Inc (CURX) Institutional Confidence - TradingKey
CURX|Curanex Pharmaceuticals Inc|Price:0.222|Chg%:+0.009 - TradingKey
Curanex Pharmaceuticals Inc (CURX) Cash Flow - TradingKey
Curanex Pharmaceuticals Inc (CURX) Balance Sheet - TradingKey
Curanex Pharmaceuticals Inc (CURX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
- po-news-eg.net
Curanex Pharmaceuticals (CURX) Slides 6% as Stock Tests Key Support at $0.18Volume Gap - dars.gov.et
Curanex Pharmaceuticals Inc Revenue Breakdown – NASDAQ:CURX - TradingView
CURX Technical Analysis | Trend, Signals & Chart Patterns - ChartMill
Curanex Pharmaceuticals (CURX) Drops 5.73%: Critical Support at $0.20 in PlayChannel Breakout - dars.gov.et
Curanex Pharmaceuticals (CURX) Edges Higher on Modest Gains, Testing Key Resistance at $0.23Cup and Handle - dars.gov.et
Curanex Pharmaceuticals (CURX) Edges Higher as Bulls Defend Key $0.26 Support LevelFactor Rotation - dars.gov.et
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
12 Health Care Stocks Moving In Monday's After-Market SessionGain Therapeutics (NASDAQ:GANX), BNB Plus - Benzinga
Form DEF 14C Curanex Pharmaceuticals Inc For: 29 June By Investing.com - Investing.com Nigeria
Curanex (CURX) OKs 5.7M-share incentive plan and 1:10–1:50 reverse split - Stock Titan
Enterprise value to EBITDA forward of Curanex Pharmaceuticals Inc – NASDAQ:CURX - TradingView
Price to book forward of Curanex Pharmaceuticals Inc – NASDAQ:CURX - TradingView
Price to sales forward of Curanex Pharmaceuticals Inc – NASDAQ:CURX - TradingView
Price to earnings forward of Curanex Pharmaceuticals Inc – NASDAQ:CURX - TradingView
Enterprise value to revenue forward of Curanex Pharmaceuticals Inc – NASDAQ:CURX - TradingView
Number of shareholders of Curanex Pharmaceuticals Inc – NASDAQ:CURX - TradingView
Curanex Pharmaceuticals (NASDAQ: CURX) approves 5.7M‑share plan and 1:10–1:50 reverse split - Stock Titan
Curanex Pharmaceuticals Inc (CURX) Valuation: PE, PB & Fair Value Analysis - TradingKey
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
PMCB Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Curanex Stock Sinks Toward 31 Cents as Nasdaq Clock Ticks - Bez Kabli
Curanex Pharmaceuticals Inc (CURX) Sees Modest Gain as Shares Test Key LevelsTechnical Analysis Picks - The Legal Advocate
CURXCuranex Pharmaceuticals Inc Stock Price and Quote - Finviz
Curanex Pharmaceuticals Inc. Faces Investigation Over Securities Fraud - GuruFocus
Finanzdaten der Curanex Pharmaceuticals Inc-Aktie (CURX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.86%
0.31%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):